Skip to main content

Chemoradiation-induced hearing loss remains a major concern for head and neck cancer patients.


Review of the literature regarding hearing loss in patients with head and neck cancer treated with chemoradiation.


Studies in the literature are reviewed that pertain to hearing loss sustained in head and neck cancer patients receiving cisplatin-based chemoradiation. Personal observations noted while treating these patients are also detailed.


PubMed was searched for pertinent articles regarding hearing loss in head and neck cancer patients receiving cisplatin chemotherapy and/or radiation.


Studies on the incidence and severity of hearing loss in head and neck cancer patients are limited, but those studies suggest that the risk of hearing loss is greater with higher-dose regimens.

View Abstract

Related Authors

Brandi Page, M.D.

Brandi Page, M.D.

Assistant Professor of Radiation Oncology and Molecular Radiation Sciences

View full profile



Nicole Schmitt, M.D.

Assistant Professor of Otolaryngology - Head and Neck Surgery

View full profile

Connect with Sibley Hospital

Connect with Surburban Hospital

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.